Attached files
| file | filename |
|---|---|
| EX-99.1 - PRESS RELEASE - ACCELLENT INC | d345307dex991.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 1, 2012
ACCELLENT INC.
(Exact name of registrant as specified in its charter)
| Maryland | 333-130470 | 84-1507827 | ||
| (State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification Number) | ||
| 100 Fordham Road Wilmington, Massachusetts |
01887 | |||
| (Address of principal executive offices) | (Zip Code) | |||
(978) 570-6900
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 8.01 Other Events.
On May 4, 2012, Accellent Inc. (the “Company”) issued a press release announcing that the Company and its wholly-owned subsidiary, MedSource Technologies Pittsburgh, Inc., entered into an Asset Purchase Agreement (the “Agreement”) with The Perryman Company (“Perryman”) to sell substantially all of the assets of the Company’s Pittsburgh operation to Perryman in exchange for approximately $8.0 million dollars in cash, subject to purchase price adjustment required under the Agreement for changes in inventory amounts through the closing date. The transaction is expected to close during the second quarter of 2012.
Prior to entering into the Agreement, Perryman supplied titanium material to the Company and will continue to do so subsequent to completion of this transaction.
| Item 9.01 | Financial Statements and Exhibits. |
| (d) | Exhibits |
| Exhibit |
Description | |
| 99.1 | Press release, dated May 4, 2012 | |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Date: May 4, 2012 | ACCELLENT INC. | |||||
| By: | /s/ Jeremy A. Friedman | |||||
| Name: Title: | Jeremy A. Friedman Chief Financial Officer | |||||
EXHIBIT INDEX
| Exhibit |
Description | |
| 99.1 | Press release, dated May 4, 2012 | |